Jefferson E, Milligan G, Johnston J, Mumtaz S, Cole C, Best J
J Med Internet Res. 2024; 26:e50235.
PMID: 39566065
PMC: 11618003.
DOI: 10.2196/50235.
Tibble H, Mueller T, Proud E, Hall E, Kurdi A, Robertson C
NPJ Prim Care Respir Med. 2024; 34(1):17.
PMID: 38942748
PMC: 11213868.
DOI: 10.1038/s41533-024-00374-x.
Macdonald C, Palmateer N, McAuley A, Lindsay L, Hasan T, Hameed S
NPJ Vaccines. 2024; 9(1):107.
PMID: 38877008
PMC: 11178861.
DOI: 10.1038/s41541-024-00898-w.
Jeffrey K, Woolford L, Maini R, Basetti S, Batchelor A, Weatherill D
EClinicalMedicine. 2024; 71:102590.
PMID: 38623399
PMC: 11016856.
DOI: 10.1016/j.eclinm.2024.102590.
Wilton J, Abdulmenan J, Chong M, Becerra A, Najmul Hussain M, Harrigan S
Front Public Health. 2024; 12:1248905.
PMID: 38450137
PMC: 10914982.
DOI: 10.3389/fpubh.2024.1248905.
Risk of winter hospitalisation and death from acute respiratory infections in Scotland: national retrospective cohort study.
Shi T, Millington T, Robertson C, Jeffrey K, Katikireddi S, McCowan C
J R Soc Med. 2024; 117(7):232-246.
PMID: 38345538
PMC: 11450722.
DOI: 10.1177/01410768231223584.
Combining Digital and Molecular Approaches Using Health and Alternate Data Sources in a Next-Generation Surveillance System for Anticipating Outbreaks of Pandemic Potential.
Ramos P, Marcilio I, Bento A, Penna G, de Oliveira J, Khouri R
JMIR Public Health Surveill. 2024; 10():e47673.
PMID: 38194263
PMC: 10806444.
DOI: 10.2196/47673.
In silico transcriptional analysis of asymptomatic and severe COVID-19 patients reveals the susceptibility of severe patients to other comorbidities and non-viral pathological conditions.
Sen P, Kaur H
Hum Gene (Amst). 2023; 35:201135.
PMID: 37521006
PMC: 9754755.
DOI: 10.1016/j.humgen.2022.201135.
Accelerated waning of the humoral response to COVID-19 vaccines in obesity.
van der Klaauw A, Horner E, Pereyra-Gerber P, Agrawal U, Foster W, Spencer S
Nat Med. 2023; 29(5):1146-1154.
PMID: 37169862
PMC: 10202802.
DOI: 10.1038/s41591-023-02343-2.
Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply.
Agrawal U, Robertson C, Sheikh A
Lancet. 2023; 401(10386):1424.
PMID: 37120282
PMC: 10139296.
DOI: 10.1016/S0140-6736(23)00444-0.
Severity of BA.2 variant and vaccine effectiveness against symptomatic disease in Scotland.
Kerr S, Robertson C, Hillman S, Grange Z, Sullivan C, Sheikh A
Lancet Reg Health Eur. 2022; 23:100533.
PMID: 36373099
PMC: 9635838.
DOI: 10.1016/j.lanepe.2022.100533.
Biases arising from linked administrative data for epidemiological research: a conceptual framework from registration to analyses.
Shaw R, Harron K, Pescarini J, Pinto Junior E, Allik M, Siroky A
Eur J Epidemiol. 2022; 37(12):1215-1224.
PMID: 36333542
PMC: 9792414.
DOI: 10.1007/s10654-022-00934-w.
Derivation of asthma severity from electronic prescription records using British thoracic society treatment steps.
Tibble H, Sheikh A, Tsanas A
BMC Pulm Med. 2022; 22(1):397.
PMID: 36329425
PMC: 9635147.
DOI: 10.1186/s12890-022-02189-3.
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
Agrawal U, Bedston S, McCowan C, Oke J, Patterson L, Robertson C
Lancet. 2022; 400(10360):1305-1320.
PMID: 36244382
PMC: 9560746.
DOI: 10.1016/S0140-6736(22)01656-7.
Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study.
Stock S, Moore E, Calvert C, Carruthers J, Denny C, Donaghy J
Lancet Respir Med. 2022; 10(12):1129-1136.
PMID: 36216011
PMC: 9708088.
DOI: 10.1016/S2213-2600(22)00360-5.
BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12-17 years in Scotland.
Rudan I, Millington T, Antal K, Grange Z, Fenton L, Sullivan C
Lancet Reg Health Eur. 2022; 23:100513.
PMID: 36189425
PMC: 9514975.
DOI: 10.1016/j.lanepe.2022.100513.
Risk of COVID-19 hospitalizations among school-aged children in Scotland: A national incident cohort study.
Shi T, Pan J, Moore E, Katikireddi S, Docherty A, Fenton L
J Glob Health. 2022; 12:05044.
PMID: 36134546
PMC: 9494196.
DOI: 10.7189/jogh.12.05044.
Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study.
Florentino P, Millington T, Cerqueira-Silva T, Robertson C, Oliveira V, Junior J
Lancet Infect Dis. 2022; 22(11):1577-1586.
PMID: 35952702
PMC: 9359673.
DOI: 10.1016/S1473-3099(22)00451-0.
COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland.
Kerr S, Vasileiou E, Robertson C, Sheikh A
J Glob Health. 2022; 12:05025.
PMID: 35802764
PMC: 9269984.
DOI: 10.7189/jogh.12.05025.
Deriving and validating a risk prediction model for long COVID-19: protocol for an observational cohort study using linked Scottish data.
Daines L, H Mulholland R, Vasileiou E, Hammersley V, Weatherill D, Katikireddi S
BMJ Open. 2022; 12(7):e059385.
PMID: 35793922
PMC: 9260199.
DOI: 10.1136/bmjopen-2021-059385.
